Altavant Sciences GmbH
6 clinical trials · Sponsor
◉ Watch Altavant Sciences GmbH
| Record | Firm | Date |
|---|---|---|
| Thorough QT Study to Evaluate the Effect of Rodatristat Ethyl, Rodatristat and Its Major Metabolites on the Heart (NCT05933447) | Altavant Sciences GmbH | 2023-05-12 |
| A Single and Multiple Dose of Rodatristat Ethyl in Healthy Adult Subjects to Evaluate the Effect of Food and Safety (NCT05684640) | Altavant Sciences GmbH | 2022-09-29 |
| Multiple-Ascending Dose in Japanese Patients Bridging Study (NCT05065359) | Altavant Sciences GmbH | 2021-10-01 |
| Pharmacokinetics and Excretion of Oral [14C]-Rodatristat Ethyl (NCT05006118) | Altavant Sciences GmbH | 2021-09-23 |
| A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE) (NCT04712669) | Altavant Sciences GmbH | 2021-03-15 |
| A Study of RVT-1201 in Patients With Pulmonary Arterial Hypertension (ELEVATE 1) (NCT03924154) | Altavant Sciences GmbH | 2019-08-01 |
Track Altavant Sciences GmbH automatically
Every clearance here is in the API, with alerts when new ones post.